1. Time to engage with stem-cell therapeutics

    Interviewee/Contributer: Alain Vertès

    Organisation: London Business School

    Read more

  2. How tissue plasminogen activator was discovered

    Interviewee/Contributer: Désiré Collen

    Organisation: ThromboGenics NV

    Read more

  3. NICE exports its health technology expertise

    Interviewee/Contributer: Karen Finn

    Organisation: Mednous

    Read more

  4. Interview: 4-Antibody AG - How do you structure a biotech for divestment?

    Interviewee/Contributer: Robert Burns

    Organisation: 4-Antibody AG

    Read more

  5. A Big Pharma deal that shares risk and reward

    Interviewee/Contributer: Bahija Jalal

    Organisation: MedImmune

    Read more

  6. Focus on opthalmology: new treatment modality

    Interviewee/Contributer: Patrik de Haes

    Organisation: ThromboGenics

    Read more

  7. Stock Market Performance, April

    Interviewee/Contributer: n/a n/a

    Organisation: n/a

    Read more

  8. Due Diligence is more than a numbers game

    Interviewee/Contributer: Anthony Sedgwick

    Organisation: Silence Therapeutics

    Read more

  9. Kymab unlocks the power of the mouse

    Interviewee/Contributer: Andrew Sandham

    Organisation: Kymab Ltd

    Read more

  10. What reforms are needed for the EU clinical trials directive

    Interviewee/Contributer: Kate Law

    Organisation: Cancer Research UK

    Read more